Linda Hsu, the Director of AstraCrux Clinical Trial and Consulting Inc, is one of the co-authors of the publication “Expert consensus on contract framework and key terms for oncology drug clinical trials” in the Chinese Journal of Cancer 2022(05) Page:235-252
“肿瘤药物临床试验合同框架与关键条款专家共识” 发表于期刊 癌症 2022 年第 41卷第五期 235-252
许静仪为共同撰写专家
